GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Cash Receipts from Fees and Commissions

Acticor Biotech (XPAR:ALACT) Cash Receipts from Fees and Commissions


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.


Acticor Biotech (XPAR:ALACT) Business Description

Industry
Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.